 |
|
|
|
 |
|
|
 Kontakt |  Druckansicht |  Firma weiterempfehlen
|
Elektrovej Building 375
2800 Lyngby
Dänemark
|
|
Portrait
Symphogen is the leader in developing recombinant polyclonal antibodies (rpAb), a new class of biopharmaceuticals for the treatment or prophylaxis of serious human diseases.
Branchenbereiche
|
|
|
|
|
Top